Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor

This study has been completed.

Study NCT00039585 Information provided by National Cancer Institute (NCI)

First Received: June 6, 2002 Last Updated: December 13, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	February 2006 (Final data collection date for primary outcome measure)